Weekly Update: New diabetes clinical trial (23 items)

New diabetes clinical trial: The DAPA-MEMRI Trial Published on: October 19, 2020 at 07:00PM Conditions:   Heart Failure;   Diabetic Cardiomyopathies Interventions:   Drug: Dapagliflozin 10 milligrams [Farxiga];   Drug: Placebo Sponsors:   University of Edinburgh;   AstraZeneca;   NHS Lothian Recruiting https://clinicaltrials.gov/ct2/show/NCT04591639?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus Published on: October 19, 2020 at 07:00PM Condition:   Diabetes Mellitus Interventions:   Drug: Insulin Glargine Sansulin;   Drug: Insulin Glargine Pen Injector [Lantus] Sponsor:   Indonesia University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04591457?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of COVID-19 on Diabetes Mellitus Published on: October 19, 2020 at 07:00PM Conditions:   Diabetes Mellitus;   Covid19 Intervention:   Sponsor:   Uşak University Recruiting https://clinicaltrials.gov/ct2/show/NCT04592055?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes Published on: October 19, 2020 at 07:00PM Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: Dulaglutide;   Drug: Placebo;   Drug: Insulin Glargine Sponsor:   Eli Lilly and Company Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04591626?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes Published on: October 15, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2 Interventions:   Drug: Faster aspart;   Drug: Insulin aspart;   Drug: Insulin degludec Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04588259?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes Published on: October 16, 2020 at 07:00PM Condition:   Type 1 Diabetes Mellitus Intervention:   Biological: Tolerogenic Dendritic Cell Vaccine Sponsor:   City of Hope Medical Center Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04590872?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19 Published on: October 19, 2020 at 07:00PM Conditions:   Covid19;   Diabetes Mellitus Intervention:   Other: hospitalisation, necessity of ICU, mortality rate, lung involvement Sponsor:   Uşak University Recruiting https://clinicaltrials.gov/ct2/show/NCT04591704?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Insul-In This Together Program Published on: October 15, 2020 at 07:00PM Condition:   Type 1 Diabetes Intervention:   Behavioral: Insul-In This Together Sponsors:   Stanford University;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04589689?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Ixekizumab Diabetes Intervention Trial (I-DIT) Published on: October 15, 2020 at 07:00PM Condition:   Type1 Diabetes Mellitus Interventions:   Drug: Ixekizumab;   Drug: Placebo Sponsors:   Vastra Gotaland Region;   Eli Lilly and Company;   Gothia Forum - Center for Clinical Trial;   Statistiska konsultgruppen;   Karolinska University Laboratory Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04589325?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS HOSPITALIZED IN INTERNAL MEDICINE UNITS (MINDER Study) Published on: October 15, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Other: educational program Sponsor:   Fadoi Foundation, Italy Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04589533?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe Published on: October 15, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Diabetic Kidney Disease Interventions:   Drug: Ezetimibe 10mg;   Drug: Placebo Sponsors:   Steno Diabetes Center Copenhagen;   Department of Clinical Physiology, Nuclear Medicine and PET at Rigshospitalet Glostrup, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark;   Aase Handberg, professor, dr.med., Department of Clinical Biochemistry, Aalborg University Hospital;   Capital Region's Pharmacy (Region Hovedstadens Apotek), Marielundvej 25, 2730 Herlev, Denmark;   Alessia Fornoni, MD PhD, Professor of Medicine, Chief, Katz Family Division of Nephrology and Hypertension Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT04589351?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Patient Centered Care in Diabetes in Ecuador Published on: October 19, 2020 at 07:00PM Conditions:   Patient Satisfaction;   Patient Engagement;   Patient Empowerment;   Health Literacy;   Patient Experience Intervention:   Other: EPD Questionnaire Sponsors:   Universidad Miguel Hernandez de Elche;   Universidad Catolica Santiago de Guayaquil;   Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT04592263?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19 Published on: October 16, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Covid19 Interventions:   Behavioral: Hospital: DD-CA;   Behavioral: Hospital: Usual Care (UC) Sponsors:   Scripps Whittier Diabetes Institute;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04591015?term=diabetes&sfpd_d=14 October 19, 2020 at 04:24PM via ClinicalTrials.gov New diabetes clinical trial: Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes Published on: October 20, 2020 at 07:00PM Conditions:   Nonalcoholic Fatty Liver;   Nonalcoholic Steatohepatitis;   Fibrosis, Liver;   Type 1 Diabetes;   Cirrhosis, Liver Intervention:   Device: Transient Elastography Sponsor:   Joslin Diabetes Center Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04595474?term=diabetes&sfpd_d=14 October 20, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Efficacy of Multigrain Supplementation in Type II Diabetes Mellitus Published on: October 21, 2020 at 07:00PM Condition:   Type2 Diabetes Intervention:   Dietary Supplement: Instant multigrain supplement Sponsor:   Universiti Sains Malaysia Recruiting https://clinicaltrials.gov/ct2/show/NCT04597229?term=diabetes&sfpd_d=14 October 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus Published on: October 22, 2020 at 07:00PM Conditions:   Type 1 Diabetes;   Pregnancy, High Risk Intervention:   Drug: Insulin Sponsor:   Gianna Wilkie Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04599075?term=diabetes&sfpd_d=14 October 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes Published on: October 21, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Oral semaglutide;   Drug: Placebo (semaglutide) Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04596631?term=diabetes&sfpd_d=14 October 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab Published on: October 22, 2020 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Biological: Teplizumab;   Other: Placebo Sponsor:   Provention Bio, Inc. Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT04598893?term=diabetes&sfpd_d=14 October 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Electrical Vestibular Stimulation (VeNS) Compared to Sham Control as a Means of Improving Glycemic Control in Adults With Type 2 Diabetes Mellitus Published on: October 21, 2020 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Device: Vestal DM active device;   Behavioral: Hypo-caloric diet;   Device: Sham device Sponsor:   Neurovalens Ltd. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04595968?term=diabetes&sfpd_d=14 October 22, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus Published on: October 23, 2020 at 07:00PM Conditions:   Diabetes Mellitus;   Tuberculosis Interventions:   Drug: Isoniazid and Rifapentine (INH-RPT);   Drug: Placebo Sponsors:   Dr. Nyanda Elias Ntinginya;   Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands;   Otago University, New Zealand;   Makerere University;   St George's, University of London, United Kingdom;   Kilimanjaro Christian Medical University College (KCMUCo), Tanzania;   Uganda Martyrs Hospital Lubaga, Uganda;   King's College London Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04600167?term=diabetes&sfpd_d=14 October 23, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: A Guided Self-determination Intervention Versus Attention Control for People With Type 2 Diabetes in Outpatient Clinics Published on: October 23, 2020 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Behavioral: Guided self-determination;   Behavioral: Personal support in goal-pursuing Sponsors:   Rigshospitalet, Denmark;   Odense University Hospital;   Copenhagen Trial Unit, Center for Clinical Intervention Research;   Copenhagen University Hospital, Denmark Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04601311?term=diabetes&sfpd_d=14 October 23, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Effect of Type 1 Diabetes on Sleep Fractionation Published on: October 23, 2020 at 07:00PM Condition:   Type 1 Diabetes Intervention:   Other: Cross-sectional observational study Sponsor:   University Hospital, Grenoble Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04601519?term=diabetes&sfpd_d=14 October 23, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Adapting and Assessing the Feasibility of a Diabetes Self-management Telehealth Intervention Published on: October 23, 2020 at 07:00PM Condition:   Diabete Mellitus Interventions:   Behavioral: Rural Diabetes One-Day Education and Care program (R-D1D);   Behavioral: Diabetes Education Materials Sponsors:   University of Utah;   University of Colorado, Denver Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04600622?term=diabetes&sfpd_d=14 October 23, 2020 at 02:24PM via ClinicalTrials.gov